A systematic review of the use of atomoxetine for management of comorbid anxiety disorders in children and adolescents with attention-deficit hyperactivity disorder Publication date: September 2022 Source: Research in Developmental Disabilities, Volume 128 Author(s): Mohamed Adil Shah Khoodoruth, Sami Ouanes, Yasser Saeed Khan Read the full article ›